ScoreWhy is Novavax, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 27.43% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -32.72
2
With a fall in Net Sales of -5.18%, the company declared Very Negative results in Mar 26
- The company has declared negative results for the last 3 consecutive quarters
- The company has declared negative results in Sep 25 after 2 consecutive negative quarters
- NET SALES(Q) At USD 139.51 MM has Fallen at -50.33%
- PRE-TAX PROFIT(Q) At USD -3.14 MM has Fallen at -102.16%
- NET PROFIT(Q) At USD -4.13 MM has Fallen at -102.85%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 40.41%, its profits have risen by 439.8% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Novavax, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Novavax, Inc.
40.41%
-0.63
69.49%
S&P 500
25.22%
1.91
13.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.76%
EBIT Growth (5y)
27.43%
EBIT to Interest (avg)
-32.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
7.49
Sales to Capital Employed (avg)
2.45
Tax Ratio
2.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
82.78%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
-10.81
EV to EBIT
1.58
EV to EBITDA
1.51
EV to Capital Employed
-1.45
EV to Sales
0.79
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -91.56 MM
-26What is not working for the Company
NET SALES(Q)
At USD 139.51 MM has Fallen at -50.33%
PRE-TAX PROFIT(Q)
At USD -3.14 MM has Fallen at -102.16%
NET PROFIT(Q)
At USD -4.13 MM has Fallen at -102.85%
RAW MATERIAL COST(Y)
Grown by 20.56% (YoY
Here's what is working for Novavax, Inc.
Operating Cash Flow
Highest at USD -91.56 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Here's what is not working for Novavax, Inc.
Net Sales
At USD 139.51 MM has Fallen at -50.33%
over average net sales of the previous four periods of USD 280.87 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -3.14 MM has Fallen at -102.16%
over average net sales of the previous four periods of USD 145.35 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -4.13 MM has Fallen at -102.85%
over average net sales of the previous four periods of USD 144.84 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Raw Material Cost
Grown by 20.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
